Nuo Therapeutics, Inc. Uncategorized Contracts & Agreements

Description of securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on April 15, 2022)

Recapitalization Agreement (Filed With SEC on October 6, 2020)

Agreement for Sale of Intellectual Property between Nuo Therapeutics, Inc. and Rohto Pharmaceutical Co., Ltd (Filed With SEC on October 26, 2018)

Medical Monitor Agreement, dated October 27, 2017, between the Company and Paul Mintz (Filed With SEC on April 16, 2018)

* * * (Filed With SEC on October 24, 2016)

BACKSTOP COMMITMENT AGREEMENT (Filed With SEC on October 24, 2016)

AMENDMENT No. 5 TO LICENSING ANDDISTRIBUTION AGREEMENT (Filed With SEC on October 24, 2016)

IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE (Filed With SEC on April 28, 2016)

IndemnificationAgreement (Filed With SEC on November 13, 2014)

FIRST AMENDMENT NO. 1 TO THE SUBSCRIPTIONAGREEMENT (Filed With SEC on December 3, 2013)

FORM 10% SUBORDINATED CONVERTIBLE PROMISSORYNOTE (Filed With SEC on November 27, 2013)

SEPARATIONAGREEMENT (Filed With SEC on May 9, 2013)

REGISTRATION RIGHTSAGREEMENT (Filed With SEC on February 20, 2013)

CYTOMEDIX LETTERHEAD February 8, 2012 (Filed With SEC on February 9, 2012)

Exhibit A Securities of Cytomedix, Inc. (Filed With SEC on February 9, 2012)

ADDITIONAL DEFAULT PROVISIONS (Filed With SEC on August 15, 2011)

CYTOMEDIX, INC. (Filed With SEC on May 16, 2011)

PURCHASEAGREEMENT (Filed With SEC on October 8, 2010)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on October 8, 2010)

PURCHASEAGREEMENT (Filed With SEC on October 8, 2010)

REGISTRATION RIGHTSAGREEMENT (Filed With SEC on April 12, 2010)

ASSIGNMENTAND ASSUMPTION AGREEMENT (Filed With SEC on April 12, 2010)

FIRST ADDENDUM TO LETTER AGREEMENT (Filed With SEC on November 1, 2006)